Delivery Order SPE2DB20D3304-SPE2DB24FW5P0
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Epinephrine 0.3 mg auto-injectors. The order has a ceiling value of $1,495.30 and a period of performance through March 29, 2024. AmerisourceBergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC) with DLA that serves as the primary vehicle for the company to deliver...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Epinephrine 0.3 mg auto-injectors. The contract has a ceiling value of $6,686.03 and a period of performance through April 18, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,563,152,794 units of Epinephrine 0.3 mg auto-injectors, with a ceiling value of $2,486.59. The ultimate completion date for this delivery order is December 21, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at...
- This is a $1,229.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Epinephrine 0.3 mg auto-injector devices. The contract has an ultimate completion date of June 11, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of epinephrine 0.15 mg auto-injectors, with a total ceiling value of $3,545.04 and a period of performance through June 30, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Epinephrine 0.3 mg auto-injector devices. The contract has a ceiling value of $1,837.44 and an ultimate completion date of July 16, 2024. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Epinephrine 0.3 mg auto-injectors. The award has a ceiling value of $9,573.97 and a completion date of August 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 0.3 mg epinephrine auto-injectors. The contract has a ceiling value of $9,696.42 and a performance period extending through June 24, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,662,406 units of Epinephrine 0.3 mg auto-injectors by June 30, 2025, with a ceiling value of $8,708.58. The contract is not set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,923,953 units of Epinephrine 0.3 mg auto-injectors, with a ceiling value of $3,736.58 and a period of performance ending on April 16, 2025. The contract is not set aside and was competed openly. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- SPE2DB20D3304Indefinite Delivery Contract
- SPE2DB20D3304-SPE2DB24FW5P0Delivery Order
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical distribution company. The contract is for the delivery of Epinephrine 0.3 mg auto-injectors, with a total ceiling value of $8,389.69 and a performance period through March 19, 2024. AmerisourceBergen Drug Corp is the prime contractor on this order, which is part of a larger $999,999,999.00 indefinite delivery contract (IDC) the company holds with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. This IDC serves as the primary contract vehicle for AmerisourceBergen to deliver these critical healthcare materials to the Department of Defense. No set-aside designation was used for this specific delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 3/18/24 |